Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guowei Shi

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Journal of Surgical Oncology|May 30, 2019
A nomogram for predicting survival and retroperitoneal lymph node dissection treatment in patients with resected testicular germ cell tumorsYougen Wu, Jeffrey P Meyers, Guowei Shi, et al.
Clinical and Translational Medicine|July 29, 2021
Histone acetyltransferase 1 upregulates androgen receptor expression to modulate CRPC cell resistance to enzalutamideZhe Hong, Zhendong Xiang, Pan Zhang, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 6, 2021
USP16 regulates castration-resistant prostate cancer cell proliferation by deubiquitinating and stablizing c-MycJianchao Ge, Wandong Yu, Junhong Li, et al.
The Prostate|April 17, 2014
KLF9, a transcription factor induced in flutamide-caused cell apoptosis, inhibits AKT activation and suppresses tumor growth of prostate cancer cellsPengliang Shen, Jiabin Sun, Guiqin Xu, et al.
International Journal of Molecular Medicine|May 14, 2014
The combinatory effects of PPAR-γ agonist and survivin inhibition on the cancer stem-like phenotype and cell proliferation in bladder cancer cellsYang Wang, Hailin Tan, Dongxu Xu, et al.
Frontiers in Genetics|January 27, 2023
Identification of molecular subtypes and a prognostic signature based on chromatin regulators related genes in prostate cancerHangbin Ma, Cheng Zhou, Jianchao Ge, et al.
Biochemical and Biophysical Research Communications|January 24, 2024
ANP32B inhibition suppresses the growth of prostate cancer cells by regulating c-Myc signalingCheng Zhou, Hangbin Ma, Wandong Yu, et al.
Oncology Letters|July 12, 2017
Low expression of microRNA-30c promotes prostate cancer cells invasion involved in downregulation of KRAS proteinJun Zhang, Xilong Wang, Yangyun Wang, et al.
BMC Urology|February 6, 2024
USP54 is a potential therapeutic target in castration-resistant prostate cancerCheng Zhou, Xuehu Zhang, Hangbin Ma, et al.
Cancer Letters|March 28, 2015
17-DMCHAG, a new geldanamycin derivative, inhibits prostate cancer cells through Hsp90 inhibition and survivin downregulationJifeng Wang, Zhenyu Li, Zhiyuan Lin, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Journal of Surgical Oncology|May 30, 2019
A nomogram for predicting survival and retroperitoneal lymph node dissection treatment in patients with resected testicular germ cell tumorsYougen Wu, Jeffrey P Meyers, Guowei Shi, et al.
Clinical and Translational Medicine|July 29, 2021
Histone acetyltransferase 1 upregulates androgen receptor expression to modulate CRPC cell resistance to enzalutamideZhe Hong, Zhendong Xiang, Pan Zhang, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 6, 2021
USP16 regulates castration-resistant prostate cancer cell proliferation by deubiquitinating and stablizing c-MycJianchao Ge, Wandong Yu, Junhong Li, et al.
The Prostate|April 17, 2014
KLF9, a transcription factor induced in flutamide-caused cell apoptosis, inhibits AKT activation and suppresses tumor growth of prostate cancer cellsPengliang Shen, Jiabin Sun, Guiqin Xu, et al.
International Journal of Molecular Medicine|May 14, 2014
The combinatory effects of PPAR-γ agonist and survivin inhibition on the cancer stem-like phenotype and cell proliferation in bladder cancer cellsYang Wang, Hailin Tan, Dongxu Xu, et al.
Frontiers in Genetics|January 27, 2023
Identification of molecular subtypes and a prognostic signature based on chromatin regulators related genes in prostate cancerHangbin Ma, Cheng Zhou, Jianchao Ge, et al.
Biochemical and Biophysical Research Communications|January 24, 2024
ANP32B inhibition suppresses the growth of prostate cancer cells by regulating c-Myc signalingCheng Zhou, Hangbin Ma, Wandong Yu, et al.
Oncology Letters|July 12, 2017
Low expression of microRNA-30c promotes prostate cancer cells invasion involved in downregulation of KRAS proteinJun Zhang, Xilong Wang, Yangyun Wang, et al.
BMC Urology|February 6, 2024
USP54 is a potential therapeutic target in castration-resistant prostate cancerCheng Zhou, Xuehu Zhang, Hangbin Ma, et al.
Cancer Letters|March 28, 2015
17-DMCHAG, a new geldanamycin derivative, inhibits prostate cancer cells through Hsp90 inhibition and survivin downregulationJifeng Wang, Zhenyu Li, Zhiyuan Lin, et al.
Pageof 6